FDA Approves Melody Transcatheter Pulmonary Valve to Treat Congenital Heart Disease Patients

About 5 years after the Melody Transcatheter Pulmonary Valve was approved by the FDA under a Humanitarian Device Exemption (HDE), the Medtronic implant has now been given full PMA approval by the agency, claims the company. The Melody TPV is a minimally invasive approach to prolonging the time between open-heart surgeries for patients with a dysfunctional right ventricular outflow tract conduit caused by congenital heart disease. An HDE is intended ...

Read More
You have just read an article categorized health titled FDA Approves Melody Transcatheter Pulmonary Valve to Treat Congenital Heart Disease Patients.
Written by: editor - Wednesday, February 4, 2015

There are currently no comments for "FDA Approves Melody Transcatheter Pulmonary Valve to Treat Congenital Heart Disease Patients"

Post a Comment